References
- Ban, T. A., Healy, D., & Shorter, E. (Eds.). (1998). The rise of psychopharmacology and the story of CINP (2nd ed.). East Kilbride: CINP.
- Carter, L. P., Koek, W., & France, C. P. (2009). Behavioral analyses of GHB: Receptor mechanisms. Pharmacology & Therapeutics, 121(1), 100–114.
- Lapin, I. (2001). Phenibut (beta-phenyl-GABA): A tranquilizer and nootropic drug. CNS Drug Reviews, 7(4), 471–481.
- Magsalin, R. M., & Khan, A. Y. (2010). Withdrawal symptoms after Internet purchase of phenibut (beta-phenyl-gamma-aminobutyric acid HCl). Journal of Clinical Psychopharmacology, 30(5), 648–649.
- McDonough, M., Kennedy, N., Glasper, A., & Bearn, J. (2004). Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: A review. Drug and Alcohol Dependence, 75(1), 3–9.
- Odujebe, O., Hoffman, R., & Nelson, L. (2008). Phenibut withdrawal – A novel “nutritional supplement. Clinical Toxicology, 46(7), 605.
- Schweizer, E., & Rickels, K. (1998). Benzodiazepine dependence and withdrawal: A review of the syndrome and its clinical management. Acta Psychiatrica Scandinavica Supplementum, 393, 95–101.
- Terrence, C. F., & Fromm, G. H. (1981). Complications of baclofen withdrawal. Archives of Neurology, 38(9), 588–589.